LC
MEDP icon

Lindbrook Capital’s Medpace MEDP Stock Holding History

Lindbrook Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$83.8K Buy
275
+141
+105% +$47.4K 0.01% 745
2024
Q4 		$44.5K Buy
134
+29
+28% +$9.84K ﹤0.01% 863
2024
Q3 		$35K Sell
105
-21
-17% -$7.98K ﹤0.01% 985
2024
Q2 		$51.9K Buy
126
+21
+20% +$8.32K ﹤0.01% 782
2024
Q1 		$42.4K Hold
105
– – ﹤0.01% 838
2023
Q4 		$32.2K Buy
105
+6
+6% +$1.62K ﹤0.01% 951
2023
Q3 		$24K Buy
99
+4
+4% +$1.02K ﹤0.01% 984
2023
Q2 		$22.8K Buy
95
+5
+6% +$1.04K ﹤0.01% 1019
2023
Q1 		$16.9K Sell
90
-18
-17% -$3.72K ﹤0.01% 1153
2022
Q4 		$22.9K Sell
108
-7
-6% -$1.4K ﹤0.01% 990
2022
Q3 		$18K Buy
115
+3
+3% +$479 ﹤0.01% 1035
2022
Q2 		$17K Sell
112
-109
-49% -$15.8K ﹤0.01% 1038
2022
Q1 		$36K Sell
221
-324
-59% -$53.4K 0.01% 787
2021
Q4 		$119K Buy
+545
New +$114K 0.02% 450
2021
Q2 		– Sell
-12
Closed -$2K – 1966
2021
Q1 		$2K Buy
+12
New +$1.83K ﹤0.01% 1567

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lindbrook Capital's MEDP Position: Q1 2025 in Review

Lindbrook Capital increased its Medpace (MEDP) stake by 105% in Q1 2025, buying an estimated $47.4K and bringing the position to 275 shares worth $83.8K. The position accounts for 0.01% of the portfolio, ranked #745.

Lindbrook Capital first reported a position in MEDP in Q1 2021 and has held it in 15 quarters since. The position peaked at $119K in Q4 2021. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Lindbrook Capital held 275 shares of Medpace worth $83.8K as of Q1 2025.
  • Lindbrook Capital bought 141 Medpace shares in Q1 2025, an estimated $47.4K.
  • Medpace made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #745 holding.
  • Lindbrook Capital first reported a position in Medpace in Q1 2021 and has held it in 15 quarters since.
  • Lindbrook Capital's Medpace position peaked at $119K in Q4 2021.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.